Frontiers in Oncology (Jul 2014)

Animal models in osteosarcoma

  • Maria V eGuijarro,
  • Steven C. Ghivizzani,
  • C. Parker Gibbs

DOI
https://doi.org/10.3389/fonc.2014.00189
Journal volume & issue
Vol. 4

Abstract

Read online

Osteosarcoma (OS) is the most common non-hematologic primary tumor of bone in children and adults. High-dose cytotoxic chemotherapy and surgical resection have improved prognosis, with long-term survival for non-metastatic disease approaching 70%. However, most OS tumors are high grade and tend to rapidly develop pulmonary metastases. Despite clinical advances, patients with metastatic disease or relapse have a poor prognosis. Towards a better understanding of the molecular pathogenesis of human OS several genetically modified OS mouse models have been developed and will be reviewed here. However better animal models that more accurately recapitulate the natural progression of the disease are needed for the development of improved prognostic and diagnostic markers as well as targeted therapies for both primary and metastatic OS.

Keywords